BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 38072677)

  • 1. Chimeric Exosomes Functionalized with STING Activation for Personalized Glioblastoma Immunotherapy.
    Bao P; Gu HY; Ye JJ; He JL; Zhong Z; Yu AX; Zhang XZ
    Adv Sci (Weinh); 2024 Feb; 11(6):e2306336. PubMed ID: 38072677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Situ Sprayed Exosome-Cross-Linked Gel as Artificial Lymph Nodes for Postoperative Glioblastoma Immunotherapy.
    Bao P; Gu HY; Jiang YC; Wang JW; Wu M; Yu A; Zhong Z; Zhang XZ
    ACS Nano; 2024 May; 18(20):13266-13276. PubMed ID: 38709874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. STING activation promotes robust immune response and NK cell-mediated tumor regression in glioblastoma models.
    Berger G; Knelson EH; Jimenez-Macias JL; Nowicki MO; Han S; Panagioti E; Lizotte PH; Adu-Berchie K; Stafford A; Dimitrakakis N; Zhou L; Chiocca EA; Mooney DJ; Barbie DA; Lawler SE
    Proc Natl Acad Sci U S A; 2022 Jul; 119(28):e2111003119. PubMed ID: 35787058
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional hybrid exosomes enhanced cancer chemo-immunotherapy by activating the STING pathway.
    Cheng L; Zhang P; Liu Y; Liu Z; Tang J; Xu L; Liu J
    Biomaterials; 2023 Oct; 301():122259. PubMed ID: 37531777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Responsive Multivesicular Polymeric Nanovaccines that Codeliver STING Agonists and Neoantigens for Combination Tumor Immunotherapy.
    Su T; Cheng F; Qi J; Zhang Y; Zhou S; Mei L; Fu S; Zhang F; Lin S; Zhu G
    Adv Sci (Weinh); 2022 Aug; 9(23):e2201895. PubMed ID: 35712773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cell-intrinsic STING signaling promotes regulatory T cell induction and immunosuppression by upregulating FOXP3 transcription in cervical cancer.
    Ni H; Zhang H; Li L; Huang H; Guo H; Zhang L; Li C; Xu JX; Nie CP; Li K; Zhang X; Xia X; Li J
    J Immunother Cancer; 2022 Sep; 10(9):. PubMed ID: 36126994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent STING activation stimulates immunogenic cell death to enhance antitumor immunity in neuroblastoma.
    Wang-Bishop L; Wehbe M; Shae D; James J; Hacker BC; Garland K; Chistov PP; Rafat M; Balko JM; Wilson JT
    J Immunother Cancer; 2020 Mar; 8(1):. PubMed ID: 32169869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acid-Ionizable Iron Nanoadjuvant Augments STING Activation for Personalized Vaccination Immunotherapy of Cancer.
    Chen F; Li T; Zhang H; Saeed M; Liu X; Huang L; Wang X; Gao J; Hou B; Lai Y; Ding C; Xu Z; Xie Z; Luo M; Yu H
    Adv Mater; 2023 Mar; 35(10):e2209910. PubMed ID: 36576344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endosomolytic polymersomes increase the activity of cyclic dinucleotide STING agonists to enhance cancer immunotherapy.
    Shae D; Becker KW; Christov P; Yun DS; Lytton-Jean AKR; Sevimli S; Ascano M; Kelley M; Johnson DB; Balko JM; Wilson JT
    Nat Nanotechnol; 2019 Mar; 14(3):269-278. PubMed ID: 30664751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking Tim-3 enhances the anti-tumor immunity of STING agonist ADU-S100 by unleashing CD4
    Luo J; Pang S; Hui Z; Zhao H; Xu S; Yu W; Yang L; Sun Q; Hao X; Wei F; Wang J; Ren X
    Theranostics; 2023; 13(14):4836-4857. PubMed ID: 37771774
    [No Abstract]   [Full Text] [Related]  

  • 11. Local immunotherapy of glioblastoma: A comprehensive review of the concept.
    Sabahi M; Salehipour A; Bazl MSY; Rezaei N; Mansouri A; Borghei-Razavi H
    J Neuroimmunol; 2023 Aug; 381():578146. PubMed ID: 37451079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dendritic cell derived exosomes loaded neoantigens for personalized cancer immunotherapies.
    Li J; Li J; Peng Y; Du Y; Yang Z; Qi X
    J Control Release; 2023 Jan; 353():423-433. PubMed ID: 36470333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manganese is critical for antitumor immune responses via cGAS-STING and improves the efficacy of clinical immunotherapy.
    Lv M; Chen M; Zhang R; Zhang W; Wang C; Zhang Y; Wei X; Guan Y; Liu J; Feng K; Jing M; Wang X; Liu YC; Mei Q; Han W; Jiang Z
    Cell Res; 2020 Nov; 30(11):966-979. PubMed ID: 32839553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors.
    Bielecki PA; Lorkowski ME; Becicka WM; Atukorale PU; Moon TJ; Zhang Y; Wiese M; Covarrubias G; Ravichandran S; Karathanasis E
    Nanoscale Horiz; 2021 Feb; 6(2):156-167. PubMed ID: 33400743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A General Biomineralization Strategy to Synthesize Autologous Cancer Vaccines with cGAS-STING Activating Capacity for Postsurgical Immunotherapy.
    Li Q; Dong Z; Cao Z; Lei H; Wang C; Hao Y; Feng L; Liu Z
    ACS Nano; 2023 Jun; 17(11):10496-10510. PubMed ID: 37184402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-delivery of Phagocytosis Checkpoint Silencer and Stimulator of Interferon Genes Agonist for Synergetic Cancer Immunotherapy.
    Lu ZD; Chen YF; Shen S; Xu CF; Wang J
    ACS Appl Mater Interfaces; 2021 Jun; 13(25):29424-29438. PubMed ID: 34129318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective delivery of STING agonist using exosomes suppresses tumor growth and enhances antitumor immunity.
    McAndrews KM; Che SPY; LeBleu VS; Kalluri R
    J Biol Chem; 2021; 296():100523. PubMed ID: 33711340
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants.
    Conde E; Vercher E; Soria-Castellano M; Suarez-Olmos J; Mancheño U; Elizalde E; Rodriguez ML; Glez-Vaz J; Casares N; Rodríguez-García E; Hommel M; González-Aseguinolaza G; Uranga-Murillo I; Pardo J; Alkorta G; Melero I; Lasarte J; Hervas-Stubbs S
    J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34810235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies involving STING pathway activation for cancer immunotherapy: Mechanism and agonists.
    Pan X; Zhang W; Guo H; Wang L; Wu H; Ding L; Yang B
    Biochem Pharmacol; 2023 Jul; 213():115596. PubMed ID: 37201875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymersome-mediated cytosolic delivery of cyclic dinucleotide STING agonist enhances tumor immunotherapy.
    Zheng H; Guo B; Qiu X; Xia Y; Qu Y; Cheng L; Meng F; Zhong Z
    Bioact Mater; 2022 Oct; 16():1-11. PubMed ID: 35386324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.